Grants
Showing of 18 results
The Oxford-Harrington Rare Disease Centre Announces Newly Funded Grant Award Programs to Develop New Therapies for Friedreich’s Ataxia
Philanthropic donation of up to £650,000 (approx. $823,000 USD) will enable the launch of two new grant award programs to support the research and development of greatly needed therapeutics for Friedreich’s Ataxia (FA).
Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award
Call for proposals focused on proteostasis, senescence, and other novel approaches.
University Hospitals Physician-scientist, Linda Cummings, Selected for American Gastroenterological Association Pilot Research Award
Research will address growing problem of antimicrobial resistance in eradicating Helicobacter Pylori (H. pylori), a bacterial infection that increases the risk of gastric cancer and peptic ulcer disease.
$2 million Grant from The Roe Green Foundation Catalyzes Multidisciplinary Research Building in Uganda
Case Western Reserve and University Hospitals solidify partnership on global health initiative.
Oxford-Harrington Rare Disease Centre Opens Call for Proposals
New Scholar Award Accelerates Novel Therapies for Rare Diseases.
University Hospitals Receives $150K Grant From PetSmart Charities®
CLEVELAND, Ohio – University Hospitals and PetSmart Charities know pets have the remarkable ability to reduce feelings of stress and anxiety, improve mood and offer unconditional love. That’s why, with the help of a $150,000 grant from PetSmart...
UH Rainbow Babies & Children's First to Use Augment Therapy in a Hospital Setting to Enhance Outcomes of Physical Therapy
The program began as a Pediatric Innovation Day winner; now expanding to patients in the hospital thanks to a generous grant from the Carson Higgins Memorial Foundation.
Post-COVID study to enroll 900+ in Northeast Ohio
Local researchers to receive federal funding from NIH for a study that seeks to understand why some people have prolonged symptoms (referred to as long COVID) or develop new or returning symptoms after the acute phase of SARS-CoV-2 infection.